US Stock MarketDetailed Quotes

MDNAF Medicenna Therapeutics

Watchlist

1.057
-0.004-0.33%

15min DelayClose Nov 21 16:00 ET

80.79MMarket Cap-3886P/E (TTM)

Medicenna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-9.40%4.04M

14.54%18.67M

34.67%4M

-2.93%4.78M

33.23%5.44M

2.98%4.46M

-27.46%16.3M

-4.99%2.97M

0.49%4.92M

-50.43%4.08M

Selling and administrative expenses

-23.88%1.25M

12.51%7.87M

54.12%2.13M

-9.63%1.78M

34.07%2.3M

-14.23%1.65M

-9.40%6.99M

-28.25%1.38M

-0.30%1.97M

-12.13%1.72M

-General and administrative expense

-23.88%1.25M

12.51%7.87M

54.12%2.13M

-9.63%1.78M

34.07%2.3M

-14.23%1.65M

-9.40%6.99M

-28.25%1.38M

-0.30%1.97M

-12.13%1.72M

Research and development costs

-1.07%2.78M

16.08%10.8M

17.47%1.86M

1.56%2.99M

32.68%3.13M

16.63%2.81M

-36.78%9.3M

33.17%1.59M

1.31%2.95M

-62.32%2.36M

Depreciation amortization depletion

400.00%5K

0.00%5K

----

0.00%2K

-50.00%1K

--1K

-86.49%5K

-85.71%1K

-80.00%2K

-Depreciation and amortization

400.00%5K

0.00%5K

----

0.00%2K

-50.00%1K

--1K

-86.49%5K

-85.71%1K

-80.00%2K

Operating profit

9.40%-4.04M

-14.54%-18.67M

-34.67%-4M

2.93%-4.78M

-33.23%-5.44M

-2.98%-4.46M

27.46%-16.3M

4.99%-2.97M

-0.49%-4.92M

50.43%-4.08M

Net non-operating interest income expense

-4.62%330K

31.07%1.2M

-40.31%228K

-17.06%282K

111.11%342K

1,053.33%346K

1,224.64%914K

4,144.44%382K

2,025.00%340K

671.43%162K

Non-operating interest income

-4.62%330K

31.07%1.2M

-40.31%228K

-17.06%282K

111.11%342K

1,053.33%346K

1,224.64%914K

4,144.44%382K

2,025.00%340K

671.43%162K

Other net income (expense)

-94.16%73K

-249.60%-7.99M

-699.61%-10.13M

-114.01%-482K

-54.61%1.37M

762.76%1.25M

3,187.28%5.34M

-1,339.77%-1.27M

4,548.65%3.44M

8,791.18%3.02M

Gain on sale of security

-94.16%73K

-249.60%-7.99M

-699.61%-10.13M

-114.01%-482K

-54.61%1.37M

762.76%1.25M

3,187.28%5.34M

-1,339.77%-1.27M

4,548.65%3.44M

8,791.18%3.02M

Income before tax

-27.08%-3.64M

-153.44%-25.47M

-260.58%-13.9M

-336.20%-4.98M

-315.51%-3.72M

31.12%-2.86M

55.49%-10.05M

-20.27%-3.86M

76.26%-1.14M

89.04%-896K

Income tax

Net income

-27.08%-3.64M

-153.44%-25.47M

-260.58%-13.9M

-336.20%-4.98M

-315.51%-3.72M

31.12%-2.86M

55.49%-10.05M

-20.27%-3.86M

76.26%-1.14M

89.04%-896K

Net income continuous Operations

-27.08%-3.64M

-153.44%-25.47M

-260.58%-13.9M

-336.20%-4.98M

-315.51%-3.72M

31.12%-2.86M

55.49%-10.05M

-20.27%-3.86M

76.26%-1.14M

89.04%-896K

Minority interest income

Net income attributable to the parent company

-27.08%-3.64M

-153.44%-25.47M

-260.58%-13.9M

-336.20%-4.98M

-315.51%-3.72M

31.12%-2.86M

55.49%-10.05M

-20.27%-3.86M

76.26%-1.14M

89.04%-896K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-27.08%-3.64M

-153.44%-25.47M

-260.58%-13.9M

-336.20%-4.98M

-315.51%-3.72M

31.12%-2.86M

55.49%-10.05M

-20.27%-3.86M

76.26%-1.14M

89.04%-896K

Basic earnings per share

-25.00%-0.05

-131.25%-0.37

-233.33%-0.2

-250.00%-0.07

-400.00%-0.05

42.86%-0.04

61.90%-0.16

0.00%-0.06

77.78%-0.02

93.33%-0.01

Diluted earnings per share

-25.00%-0.05

-131.25%-0.37

-233.33%-0.2

-250.00%-0.07

-400.00%-0.05

42.86%-0.04

61.90%-0.16

0.00%-0.06

77.78%-0.02

93.33%-0.01

Dividend per share

Currency Unit

CAD

Audit Opinions

Unqualified Opinion

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-9.40%4.04M	14.54%18.67M	34.67%4M	-2.93%4.78M	33.23%5.44M	2.98%4.46M	-27.46%16.3M	-4.99%2.97M	0.49%4.92M	-50.43%4.08M
Selling and administrative expenses	-23.88%1.25M	12.51%7.87M	54.12%2.13M	-9.63%1.78M	34.07%2.3M	-14.23%1.65M	-9.40%6.99M	-28.25%1.38M	-0.30%1.97M	-12.13%1.72M
-General and administrative expense	-23.88%1.25M	12.51%7.87M	54.12%2.13M	-9.63%1.78M	34.07%2.3M	-14.23%1.65M	-9.40%6.99M	-28.25%1.38M	-0.30%1.97M	-12.13%1.72M
Research and development costs	-1.07%2.78M	16.08%10.8M	17.47%1.86M	1.56%2.99M	32.68%3.13M	16.63%2.81M	-36.78%9.3M	33.17%1.59M	1.31%2.95M	-62.32%2.36M
Depreciation amortization depletion	400.00%5K	0.00%5K	----	0.00%2K	-50.00%1K	--1K	-86.49%5K	-85.71%1K	-80.00%2K	-80.00%2K
-Depreciation and amortization	400.00%5K	0.00%5K	----	0.00%2K	-50.00%1K	--1K	-86.49%5K	-85.71%1K	-80.00%2K	-80.00%2K
Operating profit	9.40%-4.04M	-14.54%-18.67M	-34.67%-4M	2.93%-4.78M	-33.23%-5.44M	-2.98%-4.46M	27.46%-16.3M	4.99%-2.97M	-0.49%-4.92M	50.43%-4.08M
Net non-operating interest income expense	-4.62%330K	31.07%1.2M	-40.31%228K	-17.06%282K	111.11%342K	1,053.33%346K	1,224.64%914K	4,144.44%382K	2,025.00%340K	671.43%162K
Non-operating interest income	-4.62%330K	31.07%1.2M	-40.31%228K	-17.06%282K	111.11%342K	1,053.33%346K	1,224.64%914K	4,144.44%382K	2,025.00%340K	671.43%162K
Other net income (expense)	-94.16%73K	-249.60%-7.99M	-699.61%-10.13M	-114.01%-482K	-54.61%1.37M	762.76%1.25M	3,187.28%5.34M	-1,339.77%-1.27M	4,548.65%3.44M	8,791.18%3.02M
Gain on sale of security	-94.16%73K	-249.60%-7.99M	-699.61%-10.13M	-114.01%-482K	-54.61%1.37M	762.76%1.25M	3,187.28%5.34M	-1,339.77%-1.27M	4,548.65%3.44M	8,791.18%3.02M
Income before tax	-27.08%-3.64M	-153.44%-25.47M	-260.58%-13.9M	-336.20%-4.98M	-315.51%-3.72M	31.12%-2.86M	55.49%-10.05M	-20.27%-3.86M	76.26%-1.14M	89.04%-896K
Income tax
Net income	-27.08%-3.64M	-153.44%-25.47M	-260.58%-13.9M	-336.20%-4.98M	-315.51%-3.72M	31.12%-2.86M	55.49%-10.05M	-20.27%-3.86M	76.26%-1.14M	89.04%-896K
Net income continuous Operations	-27.08%-3.64M	-153.44%-25.47M	-260.58%-13.9M	-336.20%-4.98M	-315.51%-3.72M	31.12%-2.86M	55.49%-10.05M	-20.27%-3.86M	76.26%-1.14M	89.04%-896K
Minority interest income
Net income attributable to the parent company	-27.08%-3.64M	-153.44%-25.47M	-260.58%-13.9M	-336.20%-4.98M	-315.51%-3.72M	31.12%-2.86M	55.49%-10.05M	-20.27%-3.86M	76.26%-1.14M	89.04%-896K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-27.08%-3.64M	-153.44%-25.47M	-260.58%-13.9M	-336.20%-4.98M	-315.51%-3.72M	31.12%-2.86M	55.49%-10.05M	-20.27%-3.86M	76.26%-1.14M	89.04%-896K
Basic earnings per share	-25.00%-0.05	-131.25%-0.37	-233.33%-0.2	-250.00%-0.07	-400.00%-0.05	42.86%-0.04	61.90%-0.16	0.00%-0.06	77.78%-0.02	93.33%-0.01
Diluted earnings per share	-25.00%-0.05	-131.25%-0.37	-233.33%-0.2	-250.00%-0.07	-400.00%-0.05	42.86%-0.04	61.90%-0.16	0.00%-0.06	77.78%-0.02	93.33%-0.01
Dividend per share
Currency Unit	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD	CAD
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data